Jakob Grove

Jul 16, 2024 | nature.com | Jinjie Duan |Daniel F Levey |G. Bragi Walters |Emma Johnson |Arpana Agrawal |Joel Gelernter | +2 more

AbstractCannabis use disorder (CUD) and cannabis use (CU) are prevalent conditions co-occurring with attention-deficit hyperactivity disorder (ADHD). Here we report results from a cross-disorder genome-wide association study of ADHD and CUD or CU. We identified 36 concordant genome-wide significant loci for ADHD–CUD and ten loci for ADHD–CU. DRD2 was identified as an ADHD–CUD risk gene.

Oct 5, 2023 | nature.com | Robin Beaumont |Christopher Flatley |Marc Vaudel |JING CHEN |Gunn-Helen Moen |Line Skotte | +52 more

AbstractA well-functioning placenta is essential for fetal and maternal health throughout pregnancy. Using placental weight as a proxy for placental growth, we report genome-wide association analyses in the fetal (n = 65,405), maternal (n = 61,228) and paternal (n = 52,392) genomes, yielding 40 independent association signals. Twenty-six signals are classified as fetal, four maternal and three fetal and maternal. A maternal parent-of-origin effect is seen near KCNQ1.

Aug 5, 2023 | nature.com | Clara Albiñana |Hugues Aschard |Cynthia Bulik |Jakob Grove |David M. Hougaard |Thomas Werge | +5 more

AbstractThe predictive performance of polygenic scores (PGS) is largely dependent on the number of samples available to train the PGS. Increasing the sample size for a specific phenotype is expensive and takes time, but this sample size can be effectively increased by using genetically correlated phenotypes. We propose a framework to generate multi-PGS from thousands of publicly available genome-wide association studies (GWAS) with no need to individually select the most relevant ones.

Jul 18, 2023 | nature.com | Thomas D. Als |Jakob Grove |Georgios Voloudakis |Karen Therrien |Joonas Naamanka |Daniel F Levey | +15 more

AbstractDepression is a common psychiatric disorder and a leading cause of disability worldwide. Here we conducted a genome-wide association study meta-analysis of six datasets, including >1.3 million individuals (371,184 with depression) and identified 243 risk loci. Overall, 64 loci were new, including genes encoding glutamate and GABA receptors, which are targets for antidepressant drugs.

Jun 26, 2023 | nature.com | Thomas Rolland |Freddy Cliquet |Clara A. Moreau |Guillaume Huguet |Varun Warrier |Elise Douard | +7 more

Ethical approvalInformed consents from all individuals were obtained according to following ethics clearances. The SSC is a multisite effort gathering 12 recruitment sites and informed consents were obtained from all participants included in each site at the time of their initial enrollment and centralized by the Columbia University Institutional Review Board (IRB) under the protocol AAAC6306(M00Y17). All SPARK participants were recruited under a centralized IRB protocol (WCG IRB protocol no.